BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8367884)

  • 21. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
    Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes.
    Melnick RL; Kohn MC; Dunnick JK; Leininger JR
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):137-47. PubMed ID: 9465273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.
    Elcombe CR; Odum J; Foster JR; Stone S; Hasmall S; Soames AR; Kimber I; Ashby J
    Environ Health Perspect; 2002 Apr; 110(4):363-75. PubMed ID: 11940454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for measuring chemically induced cell proliferation in specific rodent target organs.
    Goldsworthy TL; Morgan KT; Popp JA; Butterworth BE
    Prog Clin Biol Res; 1991; 369():253-84. PubMed ID: 1946524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemically induced cell proliferation in carcinogenesis.
    Butterworth BE; Popp JA; Conolly RB; Goldsworthy TL
    IARC Sci Publ; 1992; (116):279-305. PubMed ID: 1428087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens.
    Cunningham ML
    Mutat Res; 1996 Sep; 365(1-3):59-69. PubMed ID: 8898989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment.
    Croy RG
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):289-302. PubMed ID: 8013422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis.
    Huff J
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):45-53. PubMed ID: 8013424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
    Melnick RL; Kohn MC; Portier CJ
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell death and cell proliferation in the control of normal and neoplastic tissue growth.
    Foster JR
    Toxicol Pathol; 2000; 28(3):441-6. PubMed ID: 10862563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation not associated with carcinogenesis in rodents and humans.
    Ward JM; Uno H; Kurata Y; Weghorst CM; Jang JJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):125-35. PubMed ID: 8013399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.
    Williams GM; Iatropoulos MJ; Jeffrey AM
    Toxicol Pathol; 2000; 28(3):388-95. PubMed ID: 10862555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical measurement of cell proliferation as replicative DNA synthesis in the liver of male Fischer 344 rats following a single exposure to nongenotoxic hepatocarcinogens and noncarcinogens.
    Ohtsuka M; Fukuda K; Yano H; Kojiro M
    Exp Toxicol Pathol; 1998 Mar; 50(1):13-7. PubMed ID: 9570496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferators: their biological and toxicological effects.
    Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
    Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
    Tsuda H; Fukushima S; Wanibuchi H; Morimura K; Nakae D; Imaida K; Tatematsu M; Hirose M; Wakabayashi K; Moore MA
    Toxicol Pathol; 2003; 31(1):80-6. PubMed ID: 12597451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.